ANA Seroconversion Psoriasis Biologics Supplementary Data

Supplementary material for a systematic review submitted to JAAD Reviews. Contains: (1) Supplementary Methods detailing search strategy, eligibility criteria, and quality assessment procedures; (2) Supplementary Discussion with extended mechanistic interpretation of ANA seroconversion across biologic classes; (3) Supplementary Table S1 with characteristics of three included prospective cohort studies (280 patients); (4) Supplementary Figure S1 (PRISMA 2020 flow diagram); and (5) Supplementary References S6-S26.